Overview

Study of AK156 in Primary Osteoporosis Patients

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of AK156 in Japanese patients with primary osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Asahi Kasei Pharma Corporation